CpG pretreatment enhances antiviral T-cell immunity against cytomegalovirus

Blood

Volumn 122, Issue 1, 2013, Pages 55-60

  Ong, Monique L ^a,b   Wikstrom, Matthew E ^a,b   Fleming, Peter ^a,b   Estcourt, Marie J ^a,b   Hertzog, Paul J ^c   Hill, Geoffrey R ^d   Andoniou, Christopher E ^a,b   Degli Esposti, Mariapia A ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b LIONS EYE INSTITUTE   (Australia)

^c HUDSON INSTITUTE OF MEDICAL RESEARCH   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; CPG OLIGONUCLEOTIDE; CPG-OLIGONUCLEOTIDE; IMMUNOLOGICAL ADJUVANT; OLIGODEOXYRIBONUCLEOTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CPG ISLAND; CROSS PRESENTATION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; IMMUNOMODULATION; INFECTION CONTROL; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIRUS IMMUNITY; VIRUS LOAD; ANIMAL; BAGG ALBINO MOUSE; GROWTH, DEVELOPMENT AND AGING; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; SPLEEN; TRANSGENIC MOUSE; VIROLOGY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGEN PRESENTATION; CD8-POSITIVE T-LYMPHOCYTES; CROSS-PRIMING; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; IMMUNOCOMPROMISED HOST; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; OLIGODEOXYRIBONUCLEOTIDES; SPLEEN;

EID: 84883716978     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2012-12-471227     Document Type: Article

References (26)

1. Joffre OP, Segura E, Savina A, Amigorena S. Cross-presentation by dendritic cells. Nat Rev Immunol. 2012;12(8):557-569.
2. Andrews DM, Andoniou CE, Granucci F, Ricciardi-Castagnoli P, Degli-Esposti MA. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat Immunol. 2001;2(11):1077-1084. (Pubitemid 33069504)
3. Redpath S, Angulo A, Gascoigne NRJ, Ghazal P. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. J Immunol. 1999;162(11):6701-6707. (Pubitemid 29309395)
4. Yewdell JW, Hill AB. Viral interference with antigen presentation. Nat Immunol. 2002;3(11):1019-1025. (Pubitemid 35363652)
5. Munks MW, Pinto AK, Doom CM, Hill AB. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. J Immunol. 2007;178(11):7235-7241. (Pubitemid 46847449)
6. Kotton CN. Management of cytomegalovirus infection in solid organ transplantation. Nat Rev Nephrol. 2010;6(12):711-721.
7. Boeckh M. Complications, diagnosis, management, and prevention of CMV infections: current and future. Hematology Am Soc Hematol Educ Program. 2011;2011:305-309.
8. Reddehase MJ. Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance. Nat Rev Immunol. 2002;2(11):831-844. (Pubitemid 37328706)
9. Pahl-Seibert MF, Juelch M, Podlech J, et al. Highly protective in vivo function of cytomegalovirus IE1 epitope-specific memory CD8 T cells purified by T-cell receptor-based cell sorting. J Virol. 2005;79(9):5400-5413. (Pubitemid 40548208)
10. Sumaria N, van Dommelen SL, Andoniou CE, Smyth MJ, Scalzo AA, Degli-Esposti MA. The roles of interferon-gamma and perforin in antiviral immunity in mice that differ in genetically determined NK-cell-mediated antiviral activity. Immunol Cell Biol. 2009;87(7):559-566.
11. Lathbury LJ, Allan JE, Shellam GR, Scalzo AA. Effect of host genotype in determining the relative roles of natural killer cells and T cells in mediating protection against murine cytomegalovirus infection. J Gen Virol. 1996;77(Pt 10):2605-2613. (Pubitemid 26348386)
12. Scalzo AA, Brown MG, Chu DT, Heusel JW, Yokoyama WM, Forbes CA. Development of intra-natural killer complex (NKC) recombinant and congenic mouse strains for mapping and functional analysis of NK cell regulatory loci. Immunogenetics. 1999;49(3):238-241. (Pubitemid 29054584)
13. Marzo AL, Lake RA, Robinson BW, Scott B. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors. Cancer Res. 1999;59(5):1071-1079. (Pubitemid 29135968)
14. Wilson NS, Behrens GMN, Lundie RJ, et al. Systemic activation of dendritic cells by Toll-like receptor ligands or malaria infection impairs cross-presentation and antiviral immunity. Nat Immunol. 2006;7(2):165-172. (Pubitemid 43135882)
15. Wingender G, Garbi N, Schumak B, et al. Systemic application of CpG-rich DNA suppresses adaptive T cell immunity via induction of IDO. Eur J Immunol. 2006;36(1):12-20. (Pubitemid 43116387)
16. Gribaudo G, Ravaglia S, Caliendo A, et al. Interferons inhibit onset of murine cytomegalovirus immediate-early gene transcription. Virology. 1993;197(1):303-311.
17. Sainz B Jr, LaMarca HL, Garry RF, Morris CA. Synergistic inhibition of human cytomegalovirus replication by interferon-alpha/beta and interferon-gamma. Virol J. 2005;2:14.
18. Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J Immunol. 1999;162(4):2291-2298. (Pubitemid 29288853)
19. Gramzinski RA, Doolan DL, Sedegah M, Davis HL, Krieg AM, Hoffman SL. Interleukin-12- and gamma interferon-dependent protection against malaria conferred by CpG oligodeoxynucleotide in mice. Infect Immun. 2001;69(3):1643-1649. (Pubitemid 32187621)
20. Dong L, Mori I, Hossain MJ, Liu B, Kimura Y. An immunostimulatory oligodeoxynucleotide containing a cytidine-guanosine motif protects senescence-accelerated mice from lethal influenza virus by augmenting the T helper type 1 response. J Gen Virol. 2003;84(Pt 6):1623-1628. (Pubitemid 36675534)
21. Hildner K, Edelson BT, Purtha WE, et al. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity. Science. 2008;322(5904):1097-1100.
22. Torti N, Walton SM, Murphy KM, Oxenius A. Batf3 transcription factor-dependent DC subsets in murine CMV infection: differential impact on T-cell priming and memory inflation. Eur J Immunol. 2011;41(9):2612-2618.
23. Nopora K, Bernhard CA, Ried C, et al. MHC class I cross-presentation by dendritic cells counteracts viral immune evasion. Front Immunol. 2012;3:348.
24. Seillet C, Jackson JT, Markey KA, et al. CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3. Blood. 2013;121(9):1574-1583.
25. Xu RH, Remakus S, Ma X, Roscoe F, Sigal LJ. Direct presentation is sufficient for an efficient anti-viral CD8+ T cell response. PLoS Pathog. 2010;6(2):e1000768.
26. Hansen SG, Powers CJ, Richards R, et al. Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus. Science. 2010;328(5974):102-106.